What is VRTX's five-year median EV/Sales?

The median, or middle weekly reading, is 8.9× over the last five years. Available history contains 818 weekly observations from Feb 21, 2011 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Vertex Pharmaceuticals (VRTX) valuation history

Above its usual range

As of Oct 22, 2026

VRTX's EV/Sales of 10.0x is higher than 74% of its available weekly readings from the last five years.

Share EV/Sales history

Shared chart range

Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/Sales at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

VRTX year-end valuation history
Reading date	EV/Sales	5-year rank
Dec 29, 2025	9.4×	67%
Dec 30, 2024	9.4×	63%
Dec 25, 2023	9.8×	64%
Dec 26, 2022	7.5×	16%
Dec 27, 2021	7.0×	9%
Dec 28, 2020	9.4×	4%
Dec 30, 2019	14.6×	30%
Dec 31, 2018	14.8×	25%
Dec 25, 2017	15.6×	50%
Dec 26, 2016	10.2×	27%

Peers on the same measure

Stock	EV/Sales	5-year rank
ABBVAbbVie	8.7×	100%
AMGNAmgen	7.4×	93%
GILDGilead Sciences	7.0×	98%
INCYIncyte	3.7×	61%

Appears in

Health Care Stocks with Low P/E Ratios and Steady Revenue Growth Stocks Below Their 5-Year Median P/E Stocks Near Their Lowest P/E Ratios in 5 Years

Research on VRTX

No published research on VRTX yet. Read how valuation percentiles work.

Loading related research…

About this history

What is VRTX's current EV/Sales?: VRTX's EV/Sales of 10.0x is higher than 74% of its available weekly readings from the last five years.
What is VRTX's five-year median EV/Sales?: The median, or middle weekly reading, is 8.9× over the last five years. Available history contains 818 weekly observations from Feb 21, 2011 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.